- Home
- PEGA vs ASND Comparison
PEGA vs ASND Comparison
Compare PEGA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEGA
- ASND
- Stock Information
- Founded
- PEGA 1983
- ASND 2006
- Country
- PEGA United States
- ASND Denmark
- Employees
- PEGA N/A
- ASND N/A
- Industry
- PEGA EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PEGA Technology
- ASND Health Care
- Exchange
- PEGA Nasdaq
- ASND Nasdaq
- Market Cap
- PEGA 6.9B
- ASND 7.7B
- IPO Year
- PEGA 1996
- ASND 2015
- Fundamental
- Price
- PEGA $96.66
- ASND $140.30
- Analyst Decision
- PEGA Buy
- ASND Strong Buy
- Analyst Count
- PEGA 10
- ASND 13
- Target Price
- PEGA $85.90
- ASND $191.77
- AVG Volume (30 Days)
- PEGA 437.1K
- ASND 427.4K
- Earning Date
- PEGA 02-12-2025
- ASND 02-05-2025
- Dividend Yield
- PEGA 0.12%
- ASND N/A
- EPS Growth
- PEGA N/A
- ASND N/A
- EPS
- PEGA 1.36
- ASND N/A
- Revenue
- PEGA $1,480,583,000.00
- ASND $365,187,374.00
- Revenue This Year
- PEGA $5.40
- ASND $7.33
- Revenue Next Year
- PEGA $7.09
- ASND $83.72
- P/E Ratio
- PEGA $70.77
- ASND N/A
- Revenue Growth
- PEGA 9.28
- ASND 115.54
- 52 Week Low
- PEGA $44.07
- ASND $111.09
- 52 Week High
- PEGA $97.94
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- PEGA 62.99
- ASND 63.13
- Support Level
- PEGA $94.38
- ASND $128.45
- Resistance Level
- PEGA $97.31
- ASND $135.71
- Average True Range (ATR)
- PEGA 2.32
- ASND 4.77
- MACD
- PEGA -0.46
- ASND 0.65
- Stochastic Oscillator
- PEGA 74.65
- ASND 91.99
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management, or BPM, with customer relationship management, or CRM, applications. The company focuses on enterprise-size customers, specifically within the financial, insurance, and healthcare fields.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.